Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.

Fresco, C; Proclemer, A; Pavan, A; Buia, G; Vicentini, A; Pavan, D; Morgera, T

Fresco, C; Proclemer, A; Pavan, A; Buia, G; Vicentini, A; Pavan, D; Morgera, T.

Affiliation

Fresco C; Istituto di Cardiologia, Ospedale S. Maria della Misericordia, Udine, Italy.

Clin Cardiol ; 19(5): 409-12, 1996 May.

Article in En | MEDLINE | ID: mdl-8723601

Subject(s)

Anti-Arrhythmia Agents/therapeutic use; Atrial Fibrillation/drug therapy; Propafenone/therapeutic use; Ventricular Dysfunction, Left/drug therapy; Adolescent; Adult; Aged; Anti-Arrhythmia Agents/administration & dosage; Anti-Arrhythmia Agents/adverse effects; Atrial Fibrillation/diagnostic imaging; Atrial Fibrillation/physiopathology; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Rate/drug effects; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone/administration & dosage; Propafenone/adverse effects; Ventricular Dysfunction, Left/diagnostic imaging; Ventricular Dysfunction, Left/physiopathology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Atrial Fibrillation / Propafenone / Ventricular Dysfunction, Left / Anti-Arrhythmia Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1996 Type: Article

Search on Google

XML

PubMed Links